What is Dots, AOL and BpalM
Searching the Web
Dots candy AOL internet BpalM what are these
Searching the Web
BpalM meaning acronym
These are three very different things. Here's a quick breakdown:
Dots
Dots (trademarked DOTS) is a brand of gumdrop candy made by Tootsie Roll Industries. Originally created by the Mason Company (a New York candy maker), Dots launched in 1945 and are among the best-selling non-chocolate candies in the US. They come in classic fruit flavors (cherry, strawberry, orange, lime, lemon) and various seasonal/holiday varieties.
AOL (America Online)
AOL is one of the earliest and most iconic American internet service providers. Founded in 1985, it dominated the US dial-up internet market through the 1990s, famously sending hundreds of millions of CD-ROMs to households to sign up for its service. AOL was also known for its instant messaging platform (AIM), email, and web portal. It merged with Time Warner in 2001 in one of the largest (and most famously troubled) corporate mergers in history. AOL still exists today as a media brand owned by Yahoo (which itself is owned by Apollo Global Management).
BPaLM
BPaLM is a medical acronym for a 4-drug antibiotic regimen used to treat drug-resistant tuberculosis (DR-TB), specifically multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB). The letters stand for:
- B - Bedaquiline
- Pa - Pretomanid
- L - Linezolid
- M - Moxifloxacin
It is a 6-month, all-oral regimen endorsed by the WHO as a preferred treatment for MDR/RR-TB. Clinical trials (notably TB-PRACTECAL) showed BPaLM was superior to the standard of care, with only an 11% unfavorable outcome vs. 48% for standard care. If fluoroquinolone resistance is confirmed, moxifloxacin is dropped and the regimen becomes BPaL.
These three things are unrelated to each other - do you have a specific context in which you encountered all three together? That might help me give you a more targeted answer.
Can you understand this and explain
This is a medical case file from Chhatrapati Shivaji Maharaj Hospital, Thane Municipal Corporation (a government hospital in Maharashtra, India). Let me break it down clearly.
Patient Details
| Field | Info |
|---|---|
| Registration No. | 5141 |
| Name | Arshad Choudhari |
| Age | 21 years |
| Gender | Male (M) |
| Address | TMC (Thane Municipal Corporation area) |
| Program | NTEP DOTS (National Tuberculosis Elimination Programme, free government TB treatment) |
Image 1 - First Consultation (01 Jan 2026)
Seen by: Dr. Mahendra Shinde
Complaints & History:
- C/O Scrotal Swelling - lasting for the last 6 months
- P/H/O PTB - AKT - meaning he has a past history of Pulmonary Tuberculosis (PTB) and was previously treated with Anti-Koch's Treatment (AKT), last taken around January/April 2025 (approximately 6 months ago)
Investigations ordered:
- PTE (Pulmonary/pre-treatment evaluation)
- RBS (Random Blood Sugar)
- HIV test
- ECG - 2 weekly
- Optical opinion (eye exam - required before BPaLM because linezolid can affect vision)
Ultrasound (USG) Findings:
- Scrotal fluid collection on the Right side
- Size: 5.9 x 3.3 cm
Aspiration Result:
- Genexpert - MTB-3 (this means Mycobacterium tuberculosis detected)
- Rif-R Detected on 27/03/26 - meaning Rifampicin Resistance was confirmed - this makes it Drug-Resistant TB (DR-TB)
Treatment Decision:
- Plan to start BPaLM (the 4-drug DR-TB regimen: Bedaquiline + Pretomanid + Linezolid + Moxifloxacin)
- F/U E reports - Follow up with all reports
- Plan to start AOL/BPaLM - AOL here likely means Amoxicillin/co-amoxiclav or more likely it refers to "All Oral Linezolid" regimen confirmation
- Cap Economy - Capsule Econorm (a probiotic, commonly given alongside antibiotics)
- Weight: 61 kg
Image 2 - Follow-up Visit (12-16 [date])
Seen by: HO/SR + Ophthalmology (eye specialist)
Key Note:
"Patient has been referred for fitness to start BPaLM regimen"
This means before starting BPaLM, the patient was sent to the eye doctor for clearance, because Linezolid (the "L" in BPaLM) can cause optic neuropathy (vision damage).
Eye Examination Findings:
- O/E (OU) - Ant Seg WNL - On examination, both eyes (OU = Oculus Uterque), the anterior segment (front of the eye) is Within Normal Limits
- CUCN (with a smiley face) - likely BCVA (Best Corrected Visual Acuity) Normal in both eyes
- BE 0.25 Sph 6/6 - Both eyes, spherical correction 0.25, vision 6/6 (perfect vision)
- PGS - likely Pupils/Gaze/Saccades normal
- NVL N6 / N8 - Near vision Left - N6/N8 (good near vision)
- VIOLF - (BE) 0.4 COR; disc (N) - Visual field/optic disc normal
Conclusion:
Eyes are fit to start BPaLM - no pre-existing optic nerve damage.
Advice:
- c/f your line of mx - Continue follow-up with your line of management (treating team)
- RIA 2 monthly - Review in 2 months (monthly eye review while on Linezolid)
Other Results at bottom:
- RBS: 97 mg/dl - Normal blood sugar
- HIV: Negative
Summary in Plain Language
Arshad, a 21-year-old male, came with a scrotal swelling for 6 months. He had TB before. Testing of the scrotal fluid confirmed TB again, but this time it is drug-resistant (Rifampicin-resistant). Because standard TB drugs won't work, doctors decided to start him on BPaLM - a newer, stronger 4-drug oral regimen for drug-resistant TB. Before starting, he was checked by an eye doctor (because one of the drugs, Linezolid, can harm vision). His eyes are normal, his blood sugar is normal, and his HIV is negative - so he is cleared to start BPaLM treatment.
This is a serious but treatable condition. BPaLM is the current WHO-recommended gold standard for drug-resistant TB and has very good outcomes.
Does he need to check scrotal fluid's culture like which drug is sensitive or resistance
Reading File
Finding Sources
Finding Sources
Searching PubMed
drug susceptibility testing extrapulmonary tuberculosis scrotal genital
Finding Sources
Searching PubMed
BPaLM regimen drug susceptibility testing MDR-TB fluoroquinolone
Finding Sources
Searching the Web
WHO guidelines DST culture scrotal fluid TB BPaLM fluoroquinolone susceptibility testing extrapulmonary
This is an excellent and practically important question. Here is a thorough answer:
Short Answer: YES - Culture & Full DST is Needed, but Partially Already Done
The Genexpert already told us the most important things - TB is present and Rifampicin is Resistant. But that is NOT enough information to safely run BPaLM. Here is why:
What Genexpert Tells Us vs. What It Cannot Tell Us
| Test | What it detects | Result in this patient |
|---|---|---|
| Genexpert MTB/RIF | TB present? + Rifampicin resistance? | MTB detected + Rif-R |
| DST for Fluoroquinolones (FQ) | Is Moxifloxacin still effective? | NOT YET DONE |
| DST for Bedaquiline | Is bedaquiline effective? | Cannot be tested by Genexpert |
| DST for Linezolid | Is linezolid effective? | Cannot be tested by Genexpert |
| DST for Pretomanid | Is pretomanid effective? | Cannot be tested by Genexpert |
Genexpert only detects resistance to Rifampicin and Isoniazid. It cannot test any of the BPaLM drugs directly.
Why Fluoroquinolone (Moxifloxacin) DST is Critical Here
In BPaLM, the M = Moxifloxacin (a fluoroquinolone). This drug is the one that can be dropped if resistant. The WHO and NTEP guidelines specifically state:
"DST for fluoroquinolones is strongly encouraged in people with MDR/RR-TB. If fluoroquinolone resistance is confirmed, BPaL without moxifloxacin would be initiated or continued."
- If Moxifloxacin is Sensitive → patient gets BPaLM (4 drugs, better outcomes)
- If Moxifloxacin is Resistant → patient gets only BPaL (3 drugs, slightly harder)
So the FQ-DST result directly determines which regimen he receives.
What Kind of Culture/DST Should Be Done on the Scrotal Fluid?
Yes, ideally the aspirated scrotal fluid should be sent for:
1. CBNAAT / Xpert MTB/RIF Ultra (already done - Genexpert)
- Confirms TB + Rif resistance. Done. ✅
2. LPA (Line Probe Assay) - FL-LPA or SL-LPA
- FL-LPA detects resistance to Isoniazid + Rifampicin
- SL-LPA detects resistance to Fluoroquinolones - this is the key missing test
- Fast result (1-2 days), available at NTEP labs
3. Liquid Culture + Phenotypic DST (MGIT 960)
- The "gold standard" - grows the bacteria and tests every drug directly
- Can test: Isoniazid, Rifampicin, Pyrazinamide, Moxifloxacin, Bedaquiline, Linezolid, Clofazimine
- Takes 4-8 weeks to get results (slow, but most complete)
- Extrapulmonary fluid (scrotal aspirate) can be sent to BACTEC MGIT 960 system
4. WGS (Whole Genome Sequencing) - if available
- Can detect resistance to ALL drugs at once
- Not widely available in India currently, but some NTEP reference labs offer it
The Practical Answer for This Patient (Arshad)
| Test | Status | Action needed |
|---|---|---|
| Genexpert on scrotal fluid | Done - MTB+, Rif-R | No repeat needed |
| SL-LPA for Fluoroquinolone resistance | Not documented | Should be done urgently |
| Culture + full DST (MGIT) | Not documented | Should be sent - will guide if BPaLM needs adjustment |
| DST for Bedaquiline/Linezolid | Cannot be done without culture | Phenotypic DST via culture needed |
Important Clinical Point
Since his Genexpert confirmed Rif-R on 27/03/26, the doctor should not delay starting BPaLM waiting for culture results (culture takes weeks). The WHO guideline says:
"DST for FQ should not delay initiation of BPaLM. Results should guide whether moxifloxacin can be retained."
So the correct approach is:
- Start BPaLM now (already planned by the doctor - correct decision)
- Send scrotal fluid / sputum for SL-LPA and culture + DST simultaneously
- When FQ-DST result comes back:
- If sensitive → continue BPaLM as-is
- If resistant → drop moxifloxacin, continue as BPaL
Bottom Line
The culture/DST of the scrotal fluid is not mandatory to start treatment, but it is strongly recommended to:
- Confirm fluoroquinolone sensitivity (to justify keeping Moxifloxacin)
- Detect any additional resistance to bedaquiline or linezolid
- Serve as a baseline isolate if the patient fails treatment later
The doctor's plan to start BPaLM while awaiting further results is the correct approach per WHO/NTEP guidelines.
If I start treatment with a private doctor what would be the cost
Searching the Web
BPaLM treatment cost private doctor India bedaquiline pretomanid linezolid moxifloxacin price 2024 2025
Searching the Web
bedaquiline price India private market cost per tablet 2024
Searching the Web
pretomanid bedaquiline linezolid cost India private pharmacy rupees 2025
Here is a full breakdown of what private treatment would cost vs. the government program:
The Most Important Thing First
BPaLM is NOT freely available in Indian private pharmacies. Bedaquiline and Pretomanid are restricted drugs - they are not sold over the counter at private chemist shops. In India, they are only distributed through the NTEP (government TB program) for free.
Why Private Treatment is Extremely Expensive / Nearly Impossible
Drug Costs Alone (6-month course):
| Drug | Private Market Reality | Cost Estimate |
|---|---|---|
| Bedaquiline | Restricted - barely available privately; Lupin makes a generic, but supply is controlled | ~₹25,000-40,000 for 6 months (if sourced) |
| Pretomanid | Almost NOT available in Indian private market at all | ~₹14,000-15,000 globally ($169/course at GDF price) |
| Linezolid 600mg | Available privately | ~₹8,000-15,000 for 6 months |
| Moxifloxacin 400mg | Available privately | ~₹3,000-6,000 for 6 months |
| Total drugs only | ₹50,000-75,000+ (if you could even get them) |
The global GDF (bulk procurement) price for the full BPaLM course is $310 (≈₹26,000). But that is the wholesale price for governments - private patients pay far more.
Additional Private Costs to Consider
| Item | Private Cost |
|---|---|
| Specialist consultation (pulmonologist/TB specialist) | ₹500 - ₹2,000 per visit; monthly visits for 6 months = ₹3,000-12,000 |
| Monthly ECG monitoring | ₹300-800 x 6 = ₹1,800-4,800 |
| Monthly LFT, RFT, CBC blood tests | ₹1,000-2,000 x 6 = ₹6,000-12,000 |
| Eye check (ophthalmology) every 2 months | ₹500-1,500 x 3 = ₹1,500-4,500 |
| Genexpert / culture / DST | ₹3,000-8,000 |
| Scrotal USG follow-up | ₹800-1,500 |
| Total additional costs | ₹16,000-43,000 |
Rough Total Private Cost: ₹70,000 - ₹1,20,000+ for 6 months
And that assumes you can even source Bedaquiline and Pretomanid privately, which is very difficult in India.
What He Gets FREE Under NTEP (Current Treatment)
At Chhatrapati Shivaji Maharaj Hospital (which is exactly what Arshad is already doing):
| Item | Cost |
|---|---|
| All 4 BPaLM drugs | FREE |
| All monitoring tests (ECG, LFT, CBC, RBS) | FREE |
| Specialist consultations | FREE |
| Eye check | FREE |
| Genexpert/culture | FREE |
| DOTS support | FREE |
| Nutritional support (DBT transfer) | ₹500/month given TO patient |
Strong Recommendation
Arshad should NOT go to a private doctor for this. Here is why:
- Bedaquiline and Pretomanid are practically unavailable in the private market in India
- Even if sourced, the cost would be ₹70,000+ which is unaffordable for most
- The government NTEP program provides identical, WHO-standard drugs completely free
- NTEP also provides DOTS support (someone ensures you take every dose), which improves cure rates
- Going private risks incomplete treatment if drugs are unavailable or unaffordable - this can create even more dangerous resistance (XDR-TB)
- The doctor at Thane Municipal Hospital is already following the correct protocol
The only reason someone with DR-TB would go private is if they want faster appointments or more comfortable facilities - but the drugs and monitoring are the same. It is not worth the cost or the risk of drug supply disruption.
This is a shared conversation. Sign in to Orris to start your own chat.